Hinge Health, Inc. Class A Common Stock (HNGE)

Deferred Revenue

$416.47M

Quarterly · Period ending: · USD

HNGE logo

HNGE Deferred Revenue

Latest reported$300.86M
HNGE FY Deferred Revenue ($140.47M → $300.86M)
High-resolution chart · PNG

HNGE deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Hinge Health, Inc. Class A Common Stock Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
300,855,000
217,632,000
140,473,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.